Tower Research Capital (TRC)’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$37.2K Buy
2025
Q1
$18.6K Buy
2024
Q4
$12.4K Sell
2024
Q3
$32.4K Sell
2024
Q2
$39.4K Buy
2024
Q1
$3.81K Sell
2023
Q4
$24.8K Sell
2023
Q3
$95.7K Buy
2023
Q2
$5.83K Sell
2023
Q1
$23K Buy